Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Clinical trial NCT00517569 · UNKNOWN
Trial details
- NCT number
- NCT00517569
- Sponsor
- Genexine, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2009-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.